Natera, Inc. Operating Cash Flow decreased by 45.6% to $40.17M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $44.45M to $40.17M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a -10.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$70.56M | -$91.06M | -$98.74M | -$137.28M | -$110.85M | -$102.25M | -$81.13M | -$81.11M | -$78.54M | -$29.70M | -$57.61M | $27.00M | $3.99M | $51.79M | $52.89M | $44.45M | $37.57M | $59.39M | $73.89M | $40.17M |
| QoQ Change | — | -29.0% | -8.4% | -39.0% | +19.3% | +7.8% | +20.7% | +0.0% | +3.2% | +62.2% | -94.0% | +146.9% | -85.2% | >999% | +2.1% | -15.9% | -15.5% | +58.1% | +24.4% | -45.6% |
| YoY Change | — | — | — | — | -57.1% | -12.3% | +17.8% | +40.9% | +29.1% | +71.0% | +29.0% | +133.3% | +105.1% | +274.4% | +191.8% | +64.6% | +841.7% | +14.7% | +39.7% | -9.6% |